Healthcare & Life Sciences
Revagenix
United Statesrevagenix.com
Revagenix is a Healthcare & Life Sciences startup based in the United States, most recent round Series B, 1 tracked investor.
Activeseries-b
series-b
Stage
1
Investors
About Revagenix
Based in the United States, Revagenix is a startup. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Revagenix develops precision-engineered inhaled medicines targeting serious chronic respiratory diseases, with its lead program Rev-56 focused on non-CF bronchiectasis, entering Phase 1 clinical development in 2026.
Explore Revagenix's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.